Glycopyrronium Improved Health Status, Dyspnea, and Reduced Rescue Medication Use in Patients With Moderate-to-Severe COPD: Pooled Analysis From GEM1 and GEM2 Studies

被引:0
|
作者
Laforce, Craig
Kerwin, Edward
Spangenthal, Selwyn
D'Andrea, Peter
Henley, Michelle
Eckert, Joerg H.
Patalano, Francesco
机构
[1] North Carolina Clin Res, Raleigh, NC USA
[2] Clin Res Inst Southern Oregon, Medford, OR USA
[3] Amer Hlth Res, Charlotte, NC USA
[4] Novartis Pharmaceut, E Hanover, NJ USA
[5] Novartis Pharma AG, Basel, Switzerland
关键词
D O I
10.1378/chest.2279882
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
713A
引用
收藏
页数:2
相关论文
共 49 条
  • [1] Glycopyrronium Demonstrates Significant Improvements in Lung Function in Patients With Moderate-to-Severe COPD: Pooled Analysis From the GEM1 and GEM2 Studies
    Kerwin, Edward
    Spangenthal, Selwyn
    Miller, S. David
    D'Andrea, Peter
    Henley, Michelle
    Eckert, Joerg H.
    Patalano, Francesco
    CHEST, 2015, 148 (04)
  • [2] Cardiovascular Safety of Glycopyrronium in Patients With Moderate-to-Severe COPD: Pooled Analysis From the GEM1, GEM2, FLIGHT1, and FLIGHT2 Studies
    Kerwin, Edward
    Laforce, Craig
    Pedinoff, Andrew
    Di Giovanni, Robert
    Jessop, Nicola
    Henley, Michelle
    D'Andrea, Peter
    CHEST, 2015, 148 (04)
  • [3] Efficacy Of Inhaled Glycopyrrolate For Moderate-To-Severe COPD: A Subgroup Analysis By Gender From The Pooled Gem1 And Gem2 Studies
    Mahler, D. A.
    Satti, A.
    Spangenthal, S.
    Yadao, A.
    D'Andrea, P.
    Uddin, A.
    Franke-Bray, B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [4] Effect Of Glycopyrrolate On Lung Function, Health Status And Dyspnea In Age Subgroups: A Pooled Analysis From The Gem1 And Gem2 Studies
    Mahler, D. A.
    Kerwin, E.
    Gifford, A. H.
    Yadao, A.
    D'Andrea, P.
    Uddin, A.
    Bray, B. Franke
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [5] Efficacy And Safety Of Glycopyrronium In COPD Patients With Moderate-To-Severe Airflow Limitation: The Gem1 Study
    LaForce, C.
    Pearle, J.
    Feldman, G.
    Spangenthal, S.
    Eckert, J. H.
    Mota, F.
    Henley, M.
    D'Andrea, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [6] Cardiovascular Safety Of Twice-Daily Inhaled Glycopyrrolate In Subgroups Of Patients With Moderate-To-Severe COPD: Pooled Analysis From The Gem1, Gem2, Flight1 And Flight2 Studies
    Kerwin, E.
    LaForce, C.
    Pedinoff, A.
    Yadao, A.
    D'Andrea, P.
    Uddin, A.
    Franke-Bray, B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [7] Efficacy and safety of glycopyrrolate in patients with COPD by reversibility: pooled analysis of GEM1 and GEM2 12-week studies
    Ohar, Jill A.
    Bowling, Alyssa
    Goodin, Thomas
    Price, Barry
    Ozol-Godfrey, Ayca
    Sharma, Sanjay
    Sanjar, Shahin
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2019, 14 : 461 - 470
  • [8] Glycopyrronium Twice Daily Improves Lung Function And Health Status And Is Well Tolerated In COPD Patients With Moderate-To-Severe Airflow Limitation: The Gem2 Study
    Kerwin, E. M.
    Siler, T. M.
    Korenblat, P. E.
    White, A. C.
    Eckert, J. H.
    Cha, E.
    Mota, F.
    Andrea, P. D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [9] Effect of smoking status on lung function, patient-reported outcomes, and safety among COPD patients treated with glycopyrrolate inhalation powder: pooled analysis of GEM1 and GEM2 studies
    Donald P. Tashkin
    Thomas Goodin
    Alyssa Bowling
    Barry Price
    Ayca Ozol-Godfrey
    Sanjay Sharma
    Shahin Sanjar
    Respiratory Research, 20
  • [10] Effect of smoking status on lung function, patient-reported outcomes, and safety among COPD patients treated with glycopyrrolate inhalation powder: pooled analysis of GEM1 and GEM2 studies
    Tashkin, Donald P.
    Goodin, Thomas
    Bowling, Alyssa
    Price, Barry
    Ozol-Godfrey, Ayca
    Sharma, Sanjay
    Sanjar, Shahin
    RESPIRATORY RESEARCH, 2019, 20 (1):